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ABSTRACT 
 Eukaryotic genes architecture is characterized by incorporation of non-coding 
sequences interrupting the coding sequences. Through splicing, excision of those non-
coding sequences, known as introns, is taking place co-transcriptionally, i.e. 
synchronically with the synthesis of precursor messenger m-RNA from the template 
DNA, in a precisely-regulated manner. Alternative splicing is a phenomena where not all 
splice sets are used in each transcript processed. Thus, this process enhances the proteome 
and transcriptome complexity through generating different transcripts, with different 
functionality or stability, from a single gene. Aberrant splicing have been associated with 
a lot of disease including cancer as well as Parkinsonism. Chemical compounds or drugs 
that target splicing regulation have also been developed and characterized.  
Indole derivatives have proven before their potency in targeting serine-arginine rich 
splicing regulators of alternative splicing. In this study, alternative splicing in Arabidopsis 
have been targeted through three different Indole derivatives, 6-Methylindole, 2, 5-
Dimethylindole and 5-Bromoindole-2-Carboxylic Acid. Full transcriptomic analysis of the 
RNA-seq data generated from treated samples, at both 24 and 72 hrs time points, was 
conducted to reveal the alternative splicing modulation and gene expression patterns 
changes under those splicing modulators treatment. Interestingly, observation of  splicing 
pattern alteration under the influence of Indole derivatives used in this study indicate that 
most treatments, 4 out of 6,  and specifically after certain onset of time 72 hrs,  showed 
significant enhancement of AS, mostly through intron retention splicing events. 
Photorespiration related genes were altered frequently, on AS and/or expression level, 
under different Indole derivatives treatments and time points. More interestingly, RNA 
binding proteins and splicing factors were differentially spliced, a finding that is consistent 
with the prevalence of auto-regulatory nature of those genes.Furthermore, various 
potential functional outcomes may originate from differential splicing exhibited under 
Indole treatments. In hydrolase-like protein (AT5G17670), an alternative 5’ splice site 
skipped a pre-mature termination codon. In SR34a SR splicing factor, exon skipping event 
at the 5’ untranslated region might help the transcript escape regulatory miRNAs. Overall, 
this study shall introduce a transcriptomic snapshot of Genome-wide gene expression and 
alternative splicing after targeting serine-arginine splicing factors by Indole derivatives.  
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Chapter One: Introduction and study objectives 
1.1. Precursor m-RNA splicing in eukaryotes: 
 Once transcription starts inside the nucleus, multiple processes will cooperate to 
harmonize the flow of expressed information encoded in the genome to guarantee its 
accordance with the desired cellular functions. Major processes include messenger RNA 
(m-RNA) 5’ end capping, splicing and 3’ end polyadenlyation (addition of poly (A) tail at 
the 3’ end of the m-RNA. Further, m-RNA bases covalent modification, editing, 
degradation, localization, export to translation site in cytoplasm and translation initiation 
control are contributing to the processes of m-RNA expression tuning. [1] Together, those 
processes are known as post-transcriptional modifications. The recognition of the post-
transcriptional modifications as critical key players in regulation almost all physiological 
process in plants is remarkably increased.  [2-8] 
 The incorporation of non-coding sequences interrupting the coding sequences is a 
unique characteristic of eukaryotic genes architecture and a fundamental difference from 
prokaryotic genes.[9-11] In splicing, excision of those non-coding sequences, known as 
introns, is taking place co-transcriptionally, i.e. synchronically with the synthesis of 
precursor messenger m-RNA (pre m-RNA)  from the template DNA, in a precisely-
regulated manner.[11] A precursor m-RNA is processed into mature m-RNA by removal 
of introns and ligation of the remaining flanking coding sequences, known as exons, 
through two trans-esterification reactions into mature m-RNA molecule. This molecule 
then becomes ready to be transported from the transcription and processing site, nucleus, 
to the translation site, the cytoplasm, where ribosomes will translate it into a functional 
entity, a protein. 
 Precursor m-RNA splicing is performed by one of the largest complexes of the 
eukaryotic cell, the splicesome. Splicing machinery of the splicesome is a multifunctional 
tool that is responsible and capable of selection of splice sites (i.e. introns and exons 
sequences and junction’s definition) as well as exon-exon ligation and introns removal. 
Based on whether a single set or multiple sets of splice sites can be identified for a certain 
gene, any gene can undergo either a constitutive splicing (CS) or an alternative splicing 
(AS). In constitutive splicing, a single set of splice sites is utilized by the splicing 
machinery to produce a single mature m-RNA and a single protein from a single gene.[12, 
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13] On the other hand, in alternative splicing, splicing machinery has the potential to 
process the pre m-RNA in different ways by utilizing different combinations of splice 
sites, and as a result, generate different sets of mature m-RNAs, called splice variants or 
transcripts. Those different transcripts, consequently, are then translated and utilized to 
generate different proteins, which originated basically from the same single gene.[13, 14] 
Those different proteins generated from the same gene through AS can exhibit altered or 
modified function(s) (activity/interaction/binding properties), subcellular localization and 
stability.[15] Accordingly, alternative splicing is considered a major mechanism through 
which eukaryotes can enhance the coding potential of their genomes, increase 
transcriptome plasticity and proteome diversity. More interestingly, AS is believed to play 
a role in modulation of genes expression through modifying the relative abundances of 
functional and non-functional splice variants by non-sense mediated decay (NMD) along 
with controlling their recruitment to ribosomes and translation efficiency.[16-18] Thus, 
AS shall be regarded as a critical mechanism of post-transcriptional regulation of m-RNA. 
 Interestingly, AS was found to be extensively prevalent in intron-containing genes 
in human, as up to 95% of those genes shows an alternative splicing pattern of their pre m-
RNA.[19, 20] In plants, almost over 40% of intron-containing genes undergo alternative 
splicing.[21, 22] Recently, full transcriptome coverage techniques and de novo 
transcriptome assembly software have estimated the percentage of alternatively spliced 
genes to be 61% of intro-containing genes in Arabidopsis Thaliana.[23, 24] However, this 
prevalence of alternative splicing may increase through the continuous discovery of novel 
splice variants recruited in different developmental stages, organs, cell types or states of 
response to abiotic and biotic stress. [24-30] 
1.2. Mechanism of splicing 
 In eukaryotes, short consensus sequences lie within the introns (mostly at the 
exon/intron borders) are responsible for guiding the recruitment of different components 
of splicing machinery to the splice site. (See Fig 1.1)  At the beginning of an intron, 
5’splice site is almost 9 nucleotide long with a consensus start GU dinucleotide. On the 
other end, 3’ splice site of an intron has a consensus AG dinucleotide. Further, a 
pyrimidine rich region, called the polypyrimidine tract, is located upstream of the 3’splice 
site.  Upstream from the polypyrimidine tract, an A sequence, called a branch point, is 
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recognized by spliceosome during the first step of splicing. Collectively, those sequences, 
known as splicing signals or splicing sites, are essential components of pre-mRNA for 
substrate recognition and catalysis by the core splicing machinery.[12] Other group of 
RNA motifs, known as splicing regulatory elements (SRE), are divided into two main 
types; splicing enhancers and silencers. Interestingly, they can lie within both introns and 
exons, thus result in complex context-dependent splicing regulation. (reviewed in [31]). 
 Structurally, the spliceosome, one of the largest macromolecular complexes of a 
eukaryotic cell, is composed of both non coding RNAs as well as a plethora of protein 
splicing factors. The assembly of different splicesomal components at splicing sites is 
precisely ordered to functionally regulate and accomplish splicing of the substrate pre m-
RNA.[32-35] 
The key structure of a splicesome contains five small nuclear ribonucleoprotein complexes 
(snRNPs), designated U1,U2,U4,U5,U6. Each complex consists of a small nuclear RNA 
as well as definite set of protein factors. Those small nuclear RNAs are basically short, 
Uridine rich, non-coding, non-polyadenylated transcripts which also referred to as U1, U2, 
U4, U5, U6 snRNAs based on the Ribonucleoprotein complex they contribute to. The core 
proteins utilized in the structure of U1, U2, U4, U5 snRNPs belong mainly to the Sm 
protein family, for Smith, an autoimmune disease where patient develop antibodies against 
those proteins. However, the snRNP U6 is utilizing the related Sm-Like proteins (Lsm2 to 
Lsm8) in association with snRNAs in its core structure. [36] 
 The splicing process starts as UI snRNP interacts with the 5’ splice site of an intron.   
This interaction is mediated by base-pairing of the U1 snRNA to its complementary 
sequences within the pre-mRNA.  The U2 two auxiliary factors subunits binds to the 3’ 
splice site. While the U2AF 35 kDa bind to the intron-exon border, the U2AF 65 kD bind 
to the polyprimidine tract upstream of the 3’ splice site. All the previous events lead to 
formation what’s called complex E. Afterwards, U2 snRNP is interacting with the branch 
point via base-pairing of U2 snRNA to form complex A. Later, an assembly of the three 
complexes U4, U5, U6, is docking to the snRNP in order to form the pre-catalytic 
complex B that is made up of the whole five snRNPs. Subsequently, major rearrangements 
happen, leading to release of both U1 and U4 snRNPs as well as the formation of an 
activated complex B. 
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 Once an activated complex B is formed, the splicing reaction is initiated through 
the first trans-esterification reaction that includes cleavage of the pre-m-RNA 5’s splice 
site and ligate it to the branch point to form a lariat of the intron sequences. The second 
trans-esterification reaction takes place through cleavage of the 3’ splice site, ligating the 
two exons and release the mature spliced mRNA. The lariat released is then degraded and 
all snRNPs are recycled and recruited to other splicing process.[32] Within the catalytic 
cycle, other enzymes may contribute to the process. For example, ATP-dependent RNA 
helicases can help reconfiguring RNA-RNA interactions between snRNPs RNA and pre- 
mRNA. [37] 
 This process of pre- m RNA splicing was mainly described and characterized in 
both mammalian and yeast through biochemical purification of different components of 
the spliceosome as well as in vitro splicing functional assays. However, the splicing 
process hasn’t been studied extensively in plants, in apart because the lack of an in vitro 
splicing assay that recapitulates the splicing reaction in plant systems. Although plant 
introns have been shown to be precisely spliced in HeLa nuclear extract, mammalian 
introns weren’t efficiently spliced in plants, referring to a possible differences in the intron 
recognition mechanisms. [38-40]This may be, in part, due to the huge difference between 
the length of introns between animal, with intron length average 5 kb, and plants, where 
intron length average is only 160 bp.[41]  Moreover, intron sequence composition is 
considered to be important, with high UA content of plant introns permits efficient 
splicing. [40-42] 
 In Arabidopsis Thaliana’s genome, most of the mammalian and yeast splicing 
factors and U snRNA counterparts have been identified. That suggests that the main 
central mechanism and process of splicing reaction are conserved.[43, 44] Furthermore, 
the frequent presences of some paralogs is referring to a probable level of redundancy in 
function among splicing factors families. 
1.3. Mechanism of Alternative Splicing  
 The molecular mechanism of alternative splicing is mediated by differential use of 
some splice sites, so that not all splice sites are used to generate the mature mRNA. As a 
result, some exons can be skipped and removed with the flanking intron, a splicing event 
called exon skipping. In other events, whole introns can be retained, designated as intron 
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retention. (See Fig 1.2). More interestingly, in some events, different 5’ or 3’ splice sites 
can be utilized to incorporate variable parts of the exon or to remove variable parts of the 
intron. Those processes are known as alternative donor and alternative acceptor splicing 
events. Those splicing events contribute to the major differences between mRNA isoforms 
generated from the same gene. Encoded proteins from those different isoforms can entail 
different domain, as a sequence different biological functions. [45] Further, variations of 
the sequences of those alternative spliced isoforms can promote differential stability, 
translatability, regulation by microRNAs or subcellular localization. Some isoforms may 
be directed to RNA decay pathways as a results of alternative splicing. For example, one 
isoform that contain a retained intron can exhibit open reading frame pre-mature 
termination due to stop codon in this intron.  Also, if alternative splicing add or remove a 
sequence not divided by three, that may lead to shift of the open reading frame and 
inclusion of a pre-mature termination codon (PTC). Those PTCs can be recognized 
through NMD that rapidly and efficiently filter the cell’s transcriptome from PTC 
containing isoforms, thus saving the cell resources and energy waste on producing 
aberrant nonfunctional proteins [46-50]. Consequently, alternative splicing coupling to 
NMD may cause quantitative changes of overall and functional transcripts expression 
levels. [46, 51] 
1.4 Regulation of Alternative splicing  
 However conserved splice sites are the signals that guide the spliceosome where to 
splice, pre m-RNA contain other sequence motifs that interact with the RNA-binding 
proteins to regulate the usage of splice sites. Motifs are divided according to the 
consequence of binding to them into splicing enhancers and silencers, which can be 
located within both exons and introns.[52] This interaction between those cis-acting 
motifs in the pre m-RNA and RNA binding proteins trans-acting splicing factors to 
determine the splicing reactions outcomes is designated as the splicing code.(see Fig 1.3) 
[53, 54]In metazoans as well as plants, there are two main classes of splicing factors; 
serine-arginine rich proteins and heterogeneous nuclear Ribonucleoproteins.[31] In 
Arabidopsis Thaliana, a lot of trans-splicing factors have been identified in the genome. 
Their role in regulating alternative splicing in the context of growth, development and 
response to biotic or abiotic stress is undoubtedly of huge importance to understand a lot 
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of the plant’s physiological and pathological processes. 
1.4.1 Serine-arginine rich proteins   
 Serine-arginine rich proteins are group of proteins that entails mainly two types of 
domain; (1) one or two RNA- recognition motifs (RRMs) that binds to cis-acting motifs 
on mRNA and (2) serine-arginine rich (RS) domain that mediates protein-protein 
interactions.[55, 56] Eighteen SR proteins have been identified in Arabidopsis Thaliana 
genome. However eight of them have counterparts in metazoans, the rest ten proteins are 
plant specific. [55, 57, 58] Moreover, plant genomes show expansion of SR proteins. 
While 18 SR genes have been found in Arabidopsis, only 12 have been found in humans. 
Ectopic expression of different SR proteins have led to various physiological and 
morphological phenotypes and affected alternative splicing of a set of genes.[59, 60] 
 Alternative splicing of SR proteins has been extensively studied. Interestingly, a lot 
of SR proteins were found to auto-regulate their own expression through alternative 
splicing to produce PTC containing transcripts. Those transcripts either got translated into 
aberrant proteins that lack one or more functional domains or got degraded through NMD 
pathway. As a consequence, those events lead to alterations in transcripts abundance and 
functionality. [60-64]Conservation of alternative splicing of SR proteins evolutionarily 
suggests a physiological relevance of splicing pattern.[65]  
 It has been found that alternative splicing of SR protein RS31 across different light 
regimes to be regulated through reduced pool of plastquine in chloroplasts, suggesting that 
the retrograde signaling may use alternative splicing to orchestrate nuclear gene 
expression. [66] 
1.4.2 Heterogeneous Nuclear Ribonucleoproteins  
 Second class of splicing regulators are called heterogeneous Nuclear 
Ribonucleoproteins (hnRNPs).[67] They entails two main group of splicing factors; poly-
pyrimidine tract binding proteins and glycine rich proteins.   
 Poly-pyrimidine binding proteins are collection of factors that bind to 
polyprimidine rich motifs on introns. Extensively studies about those factors in mammals 
have revealed that they can repress or activate recognition of splice sites close to their 
binding sites. Further, it was found that the action of those factors can be mediated 
through combinatorial manner with other hnRNPs as well as other SR proteins.  [68, 69] 
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 More importantly, both poly-pyrimidine tract binding PTB1 and PTB2 shows 
negative auto-regulation through inclusion of PTC by a cassette exon splicing event.[70] 
RNA-seq analysis of the transcriptome of Arabidopsis Thaliana after over-expression or 
knock-down of PTB1 and PTB2 showed an altered splicing pattern of a plethora of 
transcripts.[24, 71]  
 Glycine rich proteins is a group of small RNA binding proteins found in higher 
plants and represents a simplified version of mammalian hnRNPs. Those proteins harbor 
RRM domain at N-terminal and a glycine stretch at the C-terminal. They have been found 
to be involved in plant responses to environmental stresses. Two family members AtGRP7 
and AtGRP8 have a prevalent role in alternative splicing. Both proteins were found to play 
a regulatory rule in circadian timing system.  AtGRP7 undergoes negative auto-regulation 
through binding to its own m-RNA. This binding lead to usage of a cryptic splice site that 
generates a transcript subject to NMD. AtGRP8 uses the same negative feedback loop to 
control its own expression. Even more interestingly, they reciprocally cross regulate each 
other‘s expression. They exhibit the first posttranscriptional feedback loop in the circadian 
system of any organism. [72-76]   
  
1.5 Alternative splicing role in plant adaptation to environmental stresses 
1.5.1 Splicing regulation in stress response 
 Due to the sessile nature of plants, they can be easily affected by change in 
environmental conditions. Significant changes in ambient light, temperature, or soil’s salt 
and water content, together referred to as abiotic stress, can greatly influence plant 
performance. In order to adapt to possible deviations in such environmental conditions, 
the plant was evolved to rapidly respond to those changes. Those responses include 
Absicic acid stress hormone induction as well as readjustment of the plant transcriptome 
to up regulate plant components that are able to promote tolerance of the plant to abiotic 
stress. However, it was found that both low and high temperature may not only modulate 
abundance of certain transcripts but also promote alterations in their alternative splicing 
patterns.[22, 77-79] Recently, alterations in pre-mRNA alternative splicing pattern was 
observed in Arabidopsis seedlings under salt stress.[80]  
 Heat shock transcription factors are key players of plant‘s response to an elevated 
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temperatures through binding to heat shock elements of heat shock proteins genes.[81] 
HsfA2 of Arabidopsis is of the most important transcription factors involve in plant’s 
thermo tolerance. HsfA2 showed two important post-transcriptional modification through 
AS. First, at 37ºC, a 31-bp mini exon in the single intron of HsfA2 is spliced into the 
transcript, generation HsfA2 II transcript. This exon retains a PTC that leads to direction 
of the transcript to NMD, thus regulation the level of HsfA2 active protein.[82] Second, at 
42ºC, another 5’ cryptic splice site is activated and resulting in another transcript, HsfA2 
III. This transcript codes for a truncated protein, S-HsfA2. This short protein retains a 
helix-turn-helix DNA binding motif and it was found to bind to HsfA2 promoter heat 
shock elements, resulting in enhancement of its own transcription. At 45ºC, only HsfA2 
III was detected rather than HsfA2 II transcript.[83] Such positive feedback loop through 
AS post-transcriptional modification is a great example of AS involvement in gene 
expression regulation during response to stress.  
 
1.5.2 SR proteins Alternative splicing in plant stress responses  
 Pre-m-RNA of Arabidopsis SR proteins has tend to show extensive AS under the 
influence of various environmental stresses and hormones. [22, 80, 84, 85] High salinity 
stress was found to introduce PTCs into the mRNA of several SR proteins through usage 
of alternative 5’, 3’ splice sites or intron retention events. 15 of the 18 Arabidopsis SR 
proteins tested showed altered pattern of alternative splicing when grown in high salinity 
environment. [80]  
 Further, a lot of SR proteins exhibit different AS under extreme temperatures. 
AtSR30 full intact ORF spanning transcript was enhanced at high temperatures and high 
light density. However, the unproductive PTC-containing transcript was suppressed under 
high temperatures.[22] Likewise, under dehydration stress, it was observed that SR45a, 
atypical SR-like protein, full functional transcript abundance increased relative to other 
splice variants.[86] All those findings were consistent with the suggested role of post-
transcriptional AS as an efficient regulator of functional transcripts and proteins 
abundances under stress conditions.  
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1.6 Signals coupling to alternative splicing regulation  
 Rapid reprogramming of the plant’s transcriptome and proteome complexity upon 
stress signal is a necessity to provide a real time response to this stress. Pre-mRNA 
splicing was found to be regulated by external signals in various studies. [30, 87-89] The 
mechanisms through which pre-m-RNA splicing is altered by signals in plants are not 
fully identified.  
 Posttranslational modifications of splicing factors and splicesomal components, 
specifically through phosphorylation, was found to regulate splicing in animals. 
Interestingly, many protein kinases that phosphorylate splicing factors have already been 
discovered in plants. [90]Moreover, many SR proteins and other splicing regulators were 
identified as phosphoproteins through phosphoproteomic analysis. [91] Hence, it may be 
possible that second messengers, like calcium or reactive oxygen species, can modulate 
the phosphorylation status of splicing modulators through controlling their corresponding 
kinases and phosphatases’ activity. [91] One example of complex regulatory loop that 
spans AS, NMD as well as phosphorylation is AFC2 gene in Arabidopsis, which codes for 
LAMMER kinase. This protein is able to phosphorylate SR proteins as well as other 
splicing factors. In previous research, it was revealed that exon skipping AS events in 
AFC2 resulted in alternative transcripts that are coupled to NMD, thus lead to alteration of 
AFC2 functional transcripts abundance. Consequently, any change in LAMMER kinase’s 
abundance can modulate the phosphorylation status as well as activity of SR splicing 
factors, which in turn modulate alternative splicing.[92] This complex feedback loop of 
AFC2 gene exemplify the complex nature of coupling between posttranscriptional and 
posttranslational modification in shaping the plant’s transcriptome, especially during 
response to stress signals.   
 As many RBPs including splicing factors was found to be sumoylated in global 
proteomic studies, it is possible that sumolylation is involved in splicing factors activity 
modulation and AS regulation. [93] Further, changes in cellular environmental conditions 
might impact RNA secondary structure and promote splicing pattern alteration. Evidence 
for RNA structure changes in response to ion and osmolyte concentration or temperature 
have already been provided in previous research. [94-97] 
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1.7 Alternative splicing modulating drugs 
 Alternative splicing has been associated with different neurological and muscular 
diseases. [98-100]. Various studies showed that alternative splicing is contributing to the 
disease development through changing the topology, solubility and signal peptides of 
integral membrane proteins.[101] Further, aberrant splicing events have been identified in 
Parkinson’s disease.[102] More specifically, in Spinal Muscle atrophy (SMA), the 
survival motor neuron (SMN) protein was revealed to be down regulated due to it exon 
skipping event of exon 7 from SMN m-RNA.[103]  In cancer related genes, alternative 
splicing has been recruited to promote oncogenesis, tumor suppression[104] and 
metastasis.[105] Changes in alternative splicing patterns have been found in various types 
of cancer. [104-107] 
 Therapies for human diseases as well as cancer therapies through splicing 
modulation have been developed.[108-110] Therapeutic approaches in splicing associated 
diseases include mainly restoring splicing through Antisense Oligonucleotides (ASO) and 
targeting splicing pathways through small molecules.  
 To restore splicing, as ASO is used to target and specifically bind to 12-50 
complementary nucleotides to  sterically block splicesomal components interaction with 
splicing enhancers, and thus lead to exon skipping, or splicing silencers, and thus result in 
exon inclusion. The efficiency of the approach has been proved through using mouse 
model for SMA disease. Using an intracerebroventricular (ICV) injection of one ASO 
(ASO-10-27) lead to dose-dependent enhancement of exon 7 inclusion, SMN protein 
synthesis, improved muscle physiology, motor function and survival rates.[111] 
Interestingly, systemic delivery of (ASO-10-27) lead to increase of SMN protein level in 
both peripheral and central nervous system as well as increase survival from 10 days to 
500 days[112]. Collectively, these good results in mouse models encouraged FDA to grant 
an approval on human clinical trials.  
 Through the small molecules approach, different splicesomal components or 
splicing factors can be targeted and lead to radical alterations in alternative splicing 
patterns. Many antitumor drugs have been found to possess splicing inhibition properties. 
Those drugs include herboxidiene, spliceostatin A, pladienolide and isoginkgetin.[113-
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116]. 
 
 All those drug showed antitumor potency over human cancer cell lines and 
xerograft mouse models.[115, 117-119] Herboxidiene and pladienolide B are structurally 
similar and both act through binding to SF3b components of the U2 snRNP thus inhibiting 
U2 snRNP function. Spliceostatin A also target a protein that is a component of U2 
snRNP, but rather than promoting general splicing inhibition, it initiates alterations in 
splicing of cell cycle genes. [120] 
 Cdc-2 like kinases (Clk kinases) are involved in phosphorylation of SR proteins, a 
process found to be critical for SR proteins activity and nuclear localization. [121, 
122]Targeting splicing through inhibition of such kinases can alter the activity of SR 
proteins splicing regulators. In previous studies, screening for molecules that alter the 
splicing of BCL-X, HIPK3, and RON transcripts hepatocarcinoma cell line have found 
amiloride as potent splicing modulator of those transcripts.[123] Cells treated with 
amiloride showed hypophosphorylated SR proteins and decreased level of SFSP3 
(SRp20).[123] Consequently, small molecules altering the activity of certain splicing 
factors can be used to modulate the alternative splicing of cancer- related genes and thus 
exhibit therapeutic potentials.  
1.8 Selective alteration of alternative splicing through targeting serine 
arginine rich splicing factors by Indole derivatives.  
 Compounds of the Indole derivatives have proven to be potent splicing inhibitors. 
Derivatives of Indole chemical nucleus showed the ability to specifically inhibit exonic 
splicing enhancer ESE dependent splicing. This action is mediated by direct and selective 
interaction with the members of serine-arginine rich proteins family. [124] 
 It was early revealed that drugs that hinder kinase activity of topoisomerase I, and 
thus disrupt the phosphorylation status of SR proteins, showed a splicing inhibition 
potential and altered the splicing pattern of many genes.[125, 126]  SR proteins 
phosphorylation posttranscriptional modification was shown to be essential for ESE-
dependent splicing. [127] Indole derivatives was found to prevent phosphorylation of RS 
domain of SR proteins by topo I kinase and to lesser extent by Clk-sty kinases.  However 
some Indole derivatives were able to inhibit both ESE events associated with SC35 or 
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SF2/ASF SR proteins, some other derivatives had specificity to one SR proteins.[124] 
 HIV-1 uses various 5’ or 3’ alternative splice sites to generate more than 40 
different m-RNA and proteins for its replication. This process is mediated by interaction 
of specific HIV m-RNA with SR proteins [128]. Remarkably, compounds of Indole 
derivatives showed potent inhibition of HIV-RNA production in HIV chronically infected 
cells. Selective and direct interaction of Indole derivatives with SR proteins family 
members may explain the splicing inhibition and alteration of HIV-1 m-RNA appeared 
under the influence of Indole derivatives. [124] 
 Further confirmation of the therapeutic potentials of Indole derived drugs (IDCs) 
have been demonstrated through targeting ESE dependent splicing involved in cancer 
metastasis.[129]  Ron (Recepteur d’origine nantais) proto-oncogene produces four 
different m-RNA transcripts. One specific transcript Δ Ron, generated through exon 11 
skipping event, has been associated with enhanced cell motility [130-132]. This splicing 
event has further linked to Epithelial- Mesenchymal transition process (EMT) and 
metastasis [133]. On molecular level, splicing of exon 11 is mediated through two 
elements, an exon silencer and exon enhancer, both present in constitutive neighboring 
exon 12.[134] Direct binding of SF2/ASF SR splicing factor, proto-oncogene up-regulated 
in many human tumors[135], to the enhancer sequence on exon 12 result eventually in 
formation of Δ Ron transcript with its consequences on cell motility and EMT. [134] 
  HeLa cells characterized by their preferential skipping of Ron exon 11 and 
expression of Δ Ron transcript has been treated with 4 different IDDs Indole derivative, 
which showed previously potent inhibition of SF2/ASF ESE-dependent splicing. Three 
different IDCs, namely IDC48, IDC78 and IDC92 (nomenclature according to the original 
study) were found to specifically inhibit skipping of exon 11 and reduce the levels of Δ 
Ron transcript. More importantly, dose effective curve showed that drug IDC92 was 
potent in Ron exon 11 inclusion even at 0.5 µm while Δ Ron became the less abundant 
transcript at 4 µm, yet such concentration yield modest effect on Caspase9 transcripts 
alternative splicing[129]. Collectively, all those findings support the therapeutic potency 
and specificity of targeting SR proteins mediated ESE-dependent alternative splicing by 
Indole derivatives.  
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1.9 Study objectives and design  
   
 In this study, we are trying to modulate alternative splicing in plants through 
targeting serine-arginine rich proteins splicing factors by three different Indole derivatives, 
6-Methylindole, 2, 5-Dimethylindole, 5-Bromoindole-2-Carboxylic Acid. Different 
derivatives of Indole nucleus have showed potency in inhibition of ESE dependent 
splicing in both in-vitro splicing systems and cell lines. To our knowledge, this is the first 
study to target ESE dependent splicing in plants.  
 
 This study aims mainly to reveal the scope of splicing alterations promoted by the 
three Indole derivatives under study. Splicing alterations shall be described in terms of 
global enhancement or decrease of AS under the effect of this derivatives. This study 
further investigate the functional categorization of genes experienced isoform shift 
between each treatment and control. Moreover, due to nature of coupling between gene 
expression and AS, the study aims too to elaborate the differential gene expression 
promoted by alteration in AS under Indole treatment. Finally, the study tries to give more 
insights into the potential molecular function changes or outcomes of certain differentially 
spliced transcripts to investigate the complex feedback and cross-regulatory roles between 
gene expression, post-transcriptional and post-translational modifications.  
 
 To achieve those objectives, paired-end RNA-seq of 32 samples (4 replicates*2 
time points* 4 conditions [1 control + 3 treatments) was used to give a snapshot of the 
transcriptome in different control, treatments and time points. Data generated was further 
analyzed for alternative splicing changes using JuncBASE, differential expression analysis 
using Tuxedo protocol, and functional insights into the differentially spliced transcripts 
using Integrative Genomic Viewer (IGV) visualization tool.    
  
  
 
 
14 
 
 
[136] 
 
 
Fig 1.1 Mechanism of Splicing and splicesomal assembly on splice site.  
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Fig 1.2 Cis acting factors and types of alternative splice events..  
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Fig 1.3 Alternative splicing regulation through trans-acting splicing factors.  
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1. Samples preparations and treatments 
  Six days old Arabidopsis Thaliana Col-0 seedlings have been transferred to plates 
that contain 6-Methylindole (MW: 131.17), 2, 5-Dimethylindole (MW: 145.20) or 5-
Bromoindole-2-Carboxylic Acid (MW: 240.05) at the same concentration of 10µm.  
Chemicals were ordered from Sigma-Aldrich, prepared in stock solutions of DMSO in 
100mM concentration and stored at -20ºC. Each drug treatment was extended to both 24 
hours and 72 hours before RNA extraction. Control samples that received no treatment 
were prepared and harvested for RNA extraction also at both 24 and 72 hrs time points. 
2.2. RNA extraction, library preparation and sequencing  
  Whole seedlings have been used for subsequent RNA extraction and sequencing. 
For RNA extraction step, total RNA was extracted first using Triazol method. Strand-
specific mRNA-seq library was prepared. Paired end sequencing was performed on 
Ilumina Hiseq2000 sequencing platform (Illumina Inc., California, USA). 
2.3. RNA-seq reads quality control and quality assessment 
  Sequencing output included 64 fastq files for 32 samples sequenced in this study, 
so that each sample generated one file of reads for each end of any fragment sequenced. 
Fastqc(v 0.11.2)[137](available online at 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) has been used to generate 
quality reports of all fastq files.   
  Fastqc reports showed that about 12 to 14 million reads per sample have been 
generated during sequencing, with a uniform read length 101. In the reports, per base 
sequence quality plots showed no base quality dropped below Phred quality score 33. 
Further, there were no overrepresented sequences, adapter content, nor reads flagged as 
poor sequences. Per Base N content was absent across all bases. Sequence quality scores 
plots showed average quality read around 37 with almost no read with overall quality 
below 33. However, a very few (around 9 bases) fluctuation in per base sequence content 
was found. Overall, as those results were consistent among the 32 study samples, the 
quality of the sequencing seemed promising and no trimming was needed to enhance the 
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quality of the data.  So, Fastq files were proceeded to the reads mapping and alignment 
untrimmed.  
2.4 RNA-seq reads alignment and junction prediction 
  Tophat software[138] has been used to align the generated reads of all the 
samples against the latest release of Arabidopsis genome sequence and annotation of gene 
models of TAIR10 (TAIR10.30 version), which was downloaded from ensemble plants 
File transfer portal at (http://plants.ensembl.org/info/website/ftp/index.html). 
   As a splice-aware aligner, Tophat first reads known junctions from the annotation 
file. From this annotation data, the software builds a transcriptome file that contains 
annotated exons and junctions coordinates. After that, Tophat uses Bowtie [139] aligner to 
map the RNA-seq reads to this transcriptome. 
   Interestingly, tophat has the ability to discover novel junctions, those junctions 
that their coordinates haven’t been supported by annotation data currently available in 
TAIR10 (version TAIR1030). Default parameters have been used in tophat run.  
  Two important files have been produced from tophat run on each sample of the 32 
samples in this study. First, a .bam file that contain the mapping information of the 
accepted reads hits.  Second, a junction.bed file that contains the information of splice 
junctions found/predicted in each sample. In our basic tophat run, novel splice site 
discovery feature was enabled, so the output contained information of known as well as 
novel junctions. The output of this run, as being the most possible inclusive, has only been 
used in all downstream analysis.  
   Another side tophat run, where novel junction discovery feature is disable, has 
been conducted. The purpose of this side run was to gain quantitative information about 
difference between known and novel splice junctions per sample. As this run will generate 
only known junctions data, comparison with the first basic tophat run, that generate 
information about both known and novel combined, has helped to infer statistics about 
both types of junctions in each sample. However, this later side run outputs haven’t been 
used in any of the downstream analysis.  
  Tophat version used was v.2.1.0. (https://ccb.jhu.edu/software/tophat/index.html). 
This version uses bowtie 2.2.6.0 as an aligner. Both programs were installed and used on 
Linux operating system on metagenomics-bio server (IP access 10.7.28.10) of the Biology 
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department, School of science and engineering, American University in Cairo. The 
terminal was accessed often through secure shell app of Google chrome internet browser.  
2.5 Differential gene expression analysis 
  Mapped reads haven been then used to assemble and quantify all transcripts in 
each of our samples, separately, through cufflinks software[140, 141] (v2.2.1), available to 
download at (http://cole-trapnell-lab.github.io/cufflinks/install/). Afterwards, annotation of 
all possible transcripts from each sample have been merged to generate one annotation file 
for all gene models possible in our samples pool. This has been achieved using cuffmerge 
program. Further, gene, isoform quantification and differential analysis between control 
and treatment in each time point has been performed through cuffdiff program. This 
differential expression analysis has been guided by the merged gene models annotation 
generated through cuffmerge in the previous step. Finally, visualization of the cuffdiff 
analysis output mainly utilized cummrbund bioconducter package 
(http://bioconductor.org) that runs on R statistical and computing programming 
environment. (https://www.r-project.org) (v3.2.3). 
 
2.6 Alternative splice events annotation from confident splice junctions 
  JuncBASE[142] (Junction Based Analysis of Splicing Events) protocol has been 
followed to accomplish identification and classification of splicing events in each sample. 
The protocol utilizes information from splice junction reads alignment of RNA-seq reads 
as well as annotated exon coordinates to analyze alternative splicing events. Furthermore, 
JuncBASE makes use of read counts assigned to exclusion and inclusion isoforms to 
develop “Percent-spliced in” value for each splicing event. JuncBASE software (v0.6) 
used in this study is available for download at 
(http://compbio.berkeley.edu/proj/juncbase/Home.html) 
  This protocol can further uses those values to identify splicing events that are 
differentially expressed across samples, which indicates a differential alternative splicing. 
JuncBASE protocol was initially developed in order to characterize both novel and 
annotated splicing events during Drosophila development as well as identify those events 
which altered upon knock down of splicing factors.  
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  As this study aims mainly to study the consequences of targeting serine-arginine 
rich proteins splicing factors on alternative splicing, JuncBASE protocol was a very good 
candidate to perform such analysis.  
  The workflow of JuncBASE starts with building a database for both reference 
annotation exons and introns from reference gene models annotation file. The same gene 
model reference annotation file used for mapping reads with Tophat has been used for this 
step. Afterwards, in order to remove putative false positive splice junctions, a plot of 
entropy scores of each sample splice junctions has been generated using plot entropy 
feature of JuncBASE. An entropy score is a function of both the total reads assigned to a 
certain splice junction, the number of possible different offsets to which those reads map 
as well as the number of reads that mapped to every offset.[143] So, splice junctions 
where many reads mapped to each of the possible offsets positions across the junction will 
receive a higher entropy score than other junctions, where many reads mapped to only one 
or two offsets positions. 
pi = reads at offset i / total reads to junction window 
Entropy = - sumi (pi * log(pi) / log2) [143]  
   In our study, and based on samples’ splice junctions entropy plots generated, an 
entropy score of 2 has been used to filter putative false positive novel junctions. This 
value was chosen as it overlaps with normal distribution curve of entropy scores of known 
reference annotated junctions. Further, a minimum overhang of 10 alignment of reads on 
either side of intron-exon boundary was required to assign this reads to this intron-exon 
junction. Those two criteria were used to generate a set of confident splice junctions for 
each sample to be used for downstream alternative splicing events identification and 
quantification. 
   To identify and quantify alternative splice events, reference annotation of introns 
and exons coordinates, created in first step, has been used to annotate introns, exons, 
confirm first and last exons as well as assign gene names and decide whether each splicing 
event is novel or previously annotated. Finally, tables of raw and length normalized counts 
of both inclusion and exclusion isoforms of every splicing events have been developed to 
be used later for differential splicing analysis.  
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 To generate counts of total and different events types in each sample, tables of length 
normalized reads counts for have been opened in Excel sheets (Microsoft office 2013, 
Microsoft Inc.). Then, plots of events counts have been generated after reading the tables 
in R programming environment through using ggplot2 CRAN package (https://cran.r-
project.org/web/packages/ggplot2/index.html). 
2.7 Differential alternative splicing analysis 
 Tables of length normalized exclusion and inclusion counts have been utilized to 
calculate percent spliced in values for each event in each samples. Percent spliced in can 
be calculated as follows: 
 
Percent spliced in = 
 
 
  To perform differential alternative splicing analysis, paired t statistical test, have 
utilized the percent spliced-in values of every splicing event to calculate the p-value of the 
difference between each treatment and its corresponding control. In the context of our 
study, 6 paired t-test have been conducted between 4 replicates populations of control and 
three treatments at two time points.  In each comparison, a table of the paired t-test results 
containing p-value of the difference in percent spliced in, the type of event, whether the 
event novel or annotated, gene name, chr number as well as genomic coordinates of 
inclusion and exclusion junctions and isoforms.  
  Further, the output tables of every paired t-test conducted has been filtered 
according to a cut-off p-value. Those events who showed a p-value lower than 0.01 have 
been chosen as statistically significant events. 
  Finally, and in order to determine the biological relevance of statistically 
significant events, lists of genes showed statistically significant differential alternative 
splicing have been created and submitted to DAVID (https://david.ncifcrf.gov/) for 
functional annotations as TAIR IDs (The Arabidopsis Information Resource ID). Results 
of functional ontologies and enrichment of each treatment group of genes have further 
plotted using ggplot2 in R programming and statistical computing environment.  
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2.8 Visualization of differentially expressed alternative splice events  
  Visualization of the mapped reads to the genome in each sample and compare 
differential coverage to certain intronic or exonic sequences among samples can help to 
infer the functional consequences of such splice events.  To achieve this step, integrative 
genomic viewer (IGV) [144] have been utilized to visualize differentially expressed 
alternative splice events. IGV starts with reads aligned in .sam format files. So, samtools 
have been used to convert .bam files for our 32 samples into .sam files.  After that, IGV 
tools, feature of IGV, have been used to generate two types of files, sorted and indexed 
.sam files of each sample. All files have been loaded on visualization session of IGV to 
generate sashimi and coverage plots for differentially expressed alternative splice events.  
 
 
  
 
 
 
                                                                                                                                                        
 
Fig2.1 Density distribution bar plot of known and annotated splice 
junctions in replicate 1 of control sample at 24 hours’ time point. 
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Samples preparations and treatments 
(1 control+ 3 treatments) * 2 time points  
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Fig2.2 Flow chart of the study design 
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CHAPTER 3: RESULTS AND DISCUSSION 
3.1 Global alterations of alternative splicing  
  From the RNA-seq data, 22478, 19166, 23577, 20897 alternative splice event 
have been annotated and discovered by JuncBASE ( with parameters specified at 
Materials and Methods) from control, 6-Methylindole, 2, 5-Dimethylindole, 5-
Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point, respectively. At 72 
hrs time point, 15340,18535,19319,26588 alternative splicing events have been described 
(See Fig 3.1). Majority of the events described at 24 hrs time point 4 samples are found to 
be novel and not previously annotated at Arabidopsis gene model annotation used. In 
contrast, majority of events described at 72 hrs time point were actually annotated. (See 
Fig3.2 and Fig3.3). Moreover, counting of each splice event type in each sample has been 
performed and plotted (See Fig 3.4). Eight types of alternative splicing events have been 
characterized in this analysis. Those events include; alternative donor or alternative 5’ 
splice site, alternative acceptor or alternative 3’ splice site, cassette exon, alternative first 
exon, alternative last exon and intron retention. In Arabidopsis, intron retention and 
alternative acceptor have been found to be the most prevalent splicing events, which is 
apparently different from humans, where cassette exon (also known as exon skipping) is 
the most prevalent splicing event. [22] 
  Our splicing events analysis has revealed global alterations in alternative splicing 
after treatment with Indole derivatives. In 4 out of 6 treated samples, alternative splicing 
analysis has showed enhancement of AS under the effect of Indole derivatives relative to 
control treatments. More interestingly, all three Indole derivative treated samples at 72 hrs 
time point showed enhancement of the alternative splicing. Pattern of splicing 
enhancement might seem to increase with the Indole derivative chemical structure 
complexity, as the degree of AS enhancement increased gradually under the effect of 6-
Methylindole, 2, 5-Dimethylindole, 5-Bromoindole-2-Carboxylic Acid, respectively. 
However, 2, 5-Dimethylindole treated samples showed AS enhancement at 24 hrs time-
point. Yet, both 6-Methylindole and 5-Bromoindole-2-Carboxylic Acid treated samples 
showed decrease in AS relative to the control sample at 24 hrs time point.  
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  This may suggest that different Indole derivatives exhibit different actions 
towards splicing alteration. The fact that the majority of enhanced AS events at 72 hrs 
time point are belonging to previously annotated splice junctions or splice events supports 
the validity of the AS enhancement and discredit the probability that the enhanced AS 
observed may result from false positively discovered splice junction or splice event.  
  Overall, those observations of global alterations of AS, mainly towards 
enhancement, is consistent with the hypothesized action of the Indole derivatives 
compounds (IDDs), where the main mechanism of action is an inhibition of ESE 
dependent alternative splicing through targeting SR proteins. Such splicing inhibition shall 
promote failure of proper splicing or removal of nearby intronic sequences and as a 
consequence expand the degree of alternative splicing event. That’s specifically valid and 
expected in an organism where intron retention represents the extreme majority of 
alternative splicing events. However, it remain unclear why the AS showed decrease in 6-
Methylindole and 5-Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point.  
  More interesting and consistent with the later hypothesis, analyzing alteration in 
each type of splicing event separately revealed that always intron retention is the most 
altered splicing event. Intron retention, 3’ alternative acceptor and 5’ alternative donor 
splicing events alteration pattern is following the same overall splicing alteration pattern 
with no exceptions. Intron retention seems to be the most enhanced splicing event 
enriched specifically at 72 hrs time point. Samples treated with 5-Bromoindole-2-
Carboxylic Acid showed almost more than double and half the number of splicing events 
appeared in the control samples. Moreover, alterations in exon skipping events, alternative 
first and last exon, coordinate exons as well as mutually exclusive exons showed slighter 
splicing alterations though those low representation of those splicing events in 
Arabidopsis transcriptome may discourage us from drawing conclusions on splicing 
pattern alteration they showed.  
  Collectively, observation of global and event specific splicing pattern alteration 
under the influence of Indole derivatives used in this study strongly recommend that after 
certain onset of time, 72 hrs,  splicing inhibition promoted by those derivatives lead to 
significant enhancement of AS, mostly and specifically intron retention splicing events.   
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3.2 Differentially spliced genes associated with Indole derivatives treatment  
  Enhancement of AS under Indole treatment lead to expression of alternative 
events that were not expressed in the control. Though, it is further interesting to 
investigate the isoform shift associated with each drug treatment and determine the 
functional scope of genes experienced such changes. Isoform shift mainly is a phenomena 
when a gene has two or more isoforms, yet only one is the most frequent relative to the 
others. In certain conditions, this distribution of isoforms is altered, so that the dominant 
isoform is shifted to be less frequent relative to one or two of the previously less frequent 
ones. Isoform shift may be recruited to produce proteins with altered or modified function, 
modify gene expression through NMD or whatever purpose to accommodate 
physiological changes associated with development, growth as well as response to 
environmental stresses.  
  JuncBASE produced percent spliced in values (for full description check 
Materials and Methods) and it was used to infer isoform shift but on splice event level.  
Splice events would be considered to contribute to isoform shift when a statistical 
significant (p-value > 0.01) change is observed in percent spliced in values between 
control and treated samples. Only events that pass this cut-off p-value limit have been 
labeled as significant and utilized in downstream functional analysis.  Plots of number of 
splice events who passed this cut-off and considered statistically significant differentially 
expressed alternative splice events have been generated. Further, plots of the number of 
genes experienced isoform shift under Indole treatment conditions at the two examined 
time points was plotted to infer how wide the scope of isoform shift promoted by 
derivatives under study. Moreover, functional categorization of the genes underwent 
isoform shift was determined and plotted to determine the scope of functions affected.  
  Our results (see Fig3.5) show that 293, 303 and 399 events in 6-Methylindole, 2, 
5-Dimethylindole and 5-Bromoindole-2-Carboxylic Acid treated samples, respectively, 
showed a statistically significant differential splicing at 24 hrs time point. However, 
187,146 and 366 statistically significant events were found, also respectively, at 72 hrs 
time point.   
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  Moreover, plots of genes exhibited differential splicing (see Fig 3.6)or isoforms 
shift showed that 148, 142 and 199 genes at 24 hrs time point  and 144,83 and 214 genes 
at 72 hrs time point were significantly altered in 6-Methylindole, 2, 5-Dimethylindole and 
5-Bromoindole-2-Carboxylic Acid samples, respectively.   
  Moreover, number of genes differentially spliced got plotted along with the types 
of splicing events to infer which splice event type experienced differential splicing more 
frequently under our study treatments. Interestingly, Alternative acceptor, rather than 
intron retention, was the most frequently differentially spliced event in most of treatments 
(see Fig 3.7). Alternative donor and intron retention have been found to be the second and 
third most frequently spliced event, respectively. Indeed, this may suggest splicing 
inhibition through Indole derivatives may recruit alternative 3’ and 5’ splice sites more 
than intron retention to introduce isoform shift in many genes.  
  Further, functional categorization of all genes got differentially spliced under our 
study treatments showed repeated enrichment of two functional categories across most of 
treated samples at the two time points, (See Fig 3.8-3.13). First function category enriched 
is RNA splicing genes (represented by terms; m-RNA processing, m-RNA splicing, RNA-
binding). Most of those genes are found to be also phospho-proteins. This is consistent 
with the previous studies which revealed extensive phosphorylation of RNA splicing and 
processing proteins[91], which suggests post-translational level of regulation of RNA 
splicing genes through phosphorylation. Yet, as Indole derivatives inhibit phosphorylation 
of SR proteins and thus render them inactivated, prevalence of auto-regulation of SR 
proteins and cross regulation between them and other phospho-proteins splicing factors 
can give an  a good explanation of the pattern of functional enrichment present. Inhibition 
of phospho- proteins serine arginine rich splicing factors lead to frequent alterations in 
their splicing patterns, as they tend to undergo auto-regulation of their alternative splicing.  
  Further, those alteration of SR proteins activity tend to cause alteration in other 
RNA processing and splicing factors due to cross regulation among RNA splicing factors. 
Glycine rich proteins, especially (GRP7 and GRP8), tend to be the most frequently 
splicing factor showed alteration of alternative splicing. More interestingly, enrichment of 
the term (kinases) in some samples may suggest a complex feedback or coupling between 
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alternative splicing post-transcriptional modification and phosphorylation posttranslational 
modification to regulate plant physiological changes and responses.  
  Another main functional category was found to be enriched in most of sample is 
chloroplast-related genes. This category was represented by the terms; chloroplast, 
thylakoid, plastid and photorespiration. Such enrichment may suggest retrograde 
regulation between chloroplast and nucleus that may be mediated through alternative 
splicing. It is further consistent with the recent idea suggesting the role of AS in plant’s 
response to light and promotion of photo-respiration. [145] 
  Finally, enrichment of transcription, transcriptional regulation or nucleic acid 
binding related genes among differentially alternatively spliced genes in some treated 
samples may confirm another way of controlling expression level of downstream target 
genes through other than NMD which includes AS of transcription factors.  
 
3.3 Differential gene expression analysis  
  Gene expression differential analysis revealed that 9179,9325 and 12327 genes 
have been found to be differentially expressed between control and 6-Methylindole, 2, 5-
Dimethylindole and 5-Bromoindole-2-Carboxylic Acid treated sample treated samples at 
24 hrs time point, respectively. Also, 8870, 9140 and 9439 genes were further 
differentially expressed, in the same treated samples order, at 72 hrs time point. 
Differentially expressed genes are only those which showed differential expression p-
value <0.01.  
  Due to that huge number of genes differentially expressed (which ranges from 25-
35% of around 33 thousand genes in Arabidopsis), list of genes that showed the highest 
expression difference were generated by filtering genes (>=450) absolute expression 
difference in FPKM unit. Clustered heatmaps of those genes were also plotted for each 
pair of comparison in this study. (See Fig 3.13-3.20).  
  Clusters of genes differentially expressed along different samples ( check Table 
3.1 and 3.2) and time points showed potential consistency which may infer similarity in 
expression alteration in response to Indole derivatives under study.  Most importantly, 
different members of photosystem, photo-respiration and photosynthesis have been found 
to be differentially expressed in almost all treatments.    
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  Those members include; RBCS1A, RIBULOSE BISPHOSPHATE 
CARBOXYLASE SMALL CHAIN 1A, RBCS2B, RBCB3 all belong to RBSCO family 
known for its involvement in carbon fixation using light. Further, Light Harvesting 
complex of photosystem II family members; LHC1A, LHC1B, and others were also 
frequently differentially expressed. In most treatments, up-regulation of those genes have 
been observed, especially at 24 hrs time point treated samples. Yet, down-regulation of 
those photosynthesis related families have been observed under some treatments.  
  Both of our differential expression and splicing findings reveal that 
photosynthesis and photorespiration related genes are frequently altered on the level of 
alternative splicing and gene expression under the effect of Indole derivatives used in our 
study. Those findings strongly indicate regulation of photorespiration by AS. Overall, this 
is consistent with the recent findings that Phytochrome A and B both modulate gene 
transcription and alternative splicing in response to light and to promote photorespiration 
in Arabidopsis. [145] 
3.4 Functional consequences of specific alternative splicing events promoted 
by different Indole derivative.    
  To get more insights into the molecular aspects of differential alternative splicing 
promoted by Indole derivatives under study, we utilized Integrative genomic viewer to 
plot three of the most statistically significant differentially splicing events in order to try to 
get more sense of the potential outcome of such splicing alteration.  
  First, plots of coverage data in both control and 2, 5-Dimethylindole of hydrolase-
like protein (AT5G17670) against the annotated gene model (see Fig 3.21) revealed a 
differential usage of novel 5’ splice site. First GT splice site has already been annotated in 
gene model and second splice site GT is a novel splice site that has been discovered in our 
data. Strikingly, this lower differential inclusion of 4 bases through alternative 5’ splice 
site under 2, 5-Dimethylindole treatment lead to skipping of UAG( TAG on DNA level) 
pre-mature termination codon.  Such pre-mature termination codon can have severe 
consequence on the abundance or functionality of protein, either through PTC-containing 
transcript degradation through NMD or through producing truncated protein. This 5’ 
alternative splice event has been discovered through JuncBASE and differential 5’ 
alternative donor was noted as statistically significant (p-value<0.01). 
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  Another interesting example of alternative splicing alteration in our study is 
SR34A differential exon skipping. (See Fig 3.22) SR34A is a splicing factor and one of 
serine-arginine rich proteins splicing factor, which is hypothesized to be targeted by 
Indole derivatives and is known for auto-regulating itself. Differential exon skipping 
under the effect of 2, 5 Dimethyl Indole and 6-Methyl Indole relative to control was 
discovered by JuncBASE and noted to be statistically significant alternative splicing event 
(p-value<0.01). Although this exon have been annotated in previous studies, no 
information about the functional consequences of exon skipping is available. Yet, the fact 
that the exon lies in the 5’ untranslated region of the gene model may indicate that 
skipping this exon may help the m-RNA generated to bypass regulatory mechanisms that 
target this area, like microRNA, in a similar fashion to metazoan. [146] 
  Finally, differential Intron retention event between control and 2,5-
Dimethylindole at 72 hrs time point of CPK28 calcium dependent protein kinase was 
noted to be statistically significant  (p-value<0.01). This novel intron retention has never 
been annotated in previous studies and its function remains to be elucidated. Yet, such AS 
mediated functional alteration of a protein kinase can further infer a strong coupling 
between AS and Phosphorylation, which was suggested by multiple findings in this study.   
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Fig3.1 Total AS events distribution. Counting of all splicing events discovered and 
supported by splice-junction reads from each control and treatment samples at both 24 
hrs and 72 hrs time points. 
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Fig3.2 Annotated and Novel AS events distribution. Comparison of annotated and 
novel events annotated and discovered in each sample at 24 hrs time point. 
33 
 
 
 
 
 
 
 
 
 
 
Fig3.3 Annotated and Novel AS events distribution. Comparison of annotated and 
novel events annotated and discovered in each sample at 72 hrs time point. 
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Fig3.4 Different AS events distribution. Plots of every splicing event on each sample 
at two time points. Splicing events plotted from the left to right in each graph are; 
alternative acceptor or 3’ splice site, alternative donor or 5’ splice site, alternative first 
exon, alternative last exon, co-ordinate exon, exon skipping, intron retention, mutually 
exclusive exons, and total alternative exons.  
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Fig3.5 Distribution of statistically significant differentially expressed splicing 
events. Plot shows the number of events differentially spliced at 0.01 p-value. Paired t-
test statistical test used percent spliced in values of each splicing event between control 
and each treatment at the same time point to infer differential splicing.  
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Fig3.6 Distribution of statistically significant differentially spliced genes. Plot 
shows the number of genes differentially spliced at 0.01 p-value. Paired t-test statistical 
test used percent spliced in values of each splicing event between control and each 
treatment at the same time point to infer differential splicing.  
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Fig 3.7 Genes distribution according to event splice type affecting it. Plots of genes 
differentially spliced by each splice event type in each sample at two time points. 
Splicing events plotted from the left to right in each graph are; alternative acceptor or 3’ 
splice site, alternative donor or 5’ splice site, alternative first exon, alternative last exon, 
exon skipping, intron retention and mutually exclusive exons. 
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Fig 3.8 Functional categorization of differentially spliced genes between control 
and 6-Metlyindole treated samples at 24 hrs time point. Plot contain functional 
categorization of differentially expressed genes between Control and 6-Methylindole 
treated samples at 24 hrs time point has been generated by David Functional annotation 
tool. All categories plotted exceed 1.3 log10 (1/p-value) cut-off value which is 
equivalent to 0.05 p-value. 
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Fig 3.9 Functional categorization of differentially spliced genes between control 
and 6-Metlyindole treated samples at 72 hrs time point. Plot contain functional 
categorization of differentially expressed genes between Control and 6-Methylindole 
treated samples at 72 hrs time point has been generated by David Functional annotation 
tool. All categories plotted exceed 1.3 log10 (1/p-value) cut-off value which is 
equivalent to 0.05 p-value. 
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Fig 3.10 Functional categorization of differentially spliced genes between control 
and 2, 5-Dimethylindolelyindole treated samples at 24 hrs time point. Plot contain 
functional categorization of differentially expressed genes between Control and 2,5-
Dimethylindole treated samples at 24 hrs time point has been generated by David 
Functional annotation tool. All categories plotted exceed 1.3 log10(1/p-value) cut-off 
value which is equivalent to 0.05 p-value. 
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Fig 3.11 Functional categorization of differentially spliced genes between control 
and 2, 5-Dimethylindolelyindole treated samples at 72 hrs time point. Plot contain 
functional categorization of differentially expressed genes between Control and 2,5-
Dimethylindole treated samples at 72 hrs time point has been generated by David 
Functional annotation tool. All categories plotted exceed 1.3 log10 (1/p-value) cut-off 
value which is equivalent to 0.05 p-value. 
42 
 
 
                                                                                                
 
 
 
Fig 3.12 Functional categorization of differentially spliced genes between control 
and 5-Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point. Plot 
contain functional categorization of differentially expressed genes between Control and 
5-Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point has been 
generated by David Functional annotation tool. All categories plotted exceed 1.3 log10 
(1/p-value) cut-off value which is equivalent to 0.05 p-value. 
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Fig 3.13 Functional categorization of differentially spliced genes between control 
and 5-Bromoindole-2-Carboxylic Acid treated samples at 72 hrs time point. Plot 
contain functional categorization of differentially expressed genes between Control and 
5-Bromoindole-2-Carboxylic Acid treated samples at 72 hrs time point has been 
generated by David Functional annotation tool. All categories plotted exceed 1.3 log10 
(1/p-value) cut-off value which is equivalent to 0.05 p-value. 
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Fig 3.14 Volcano plots of expression alterations under (A) 6-Methylindole at 24 hrs 
time point (B) 6-Methylindole at 72 hrs time point(C) 2, 5-Dimethylindole at 24 hrs 
time point (D) 2, 5-Dimethylindole at 72 hrs time point (E) 5-Bromoindole-2-
Carboxylic Acid at 24 hrs time point (F)5-Bromoindole-2-Carboxylic Acid at 72 hrs 
time point.  
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Fig 3.15 Heatmap of top differentially expressed genes between control and 6-
Methylindole treated samples at 24 hrs time point. Genes plotted are ones which 
showed expression difference more than or equal to 450 between two samples. 
Clustering of genes through correlation have been done through hclust function in R 
statistical programming environment.  
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Fig 3.16 Heatmap of top differentially expressed genes between control and 2, 5-
Dimethylindole treated samples at 24 hrs time point. Genes plotted are ones which 
showed expression difference more than or equal to 450 between two samples. 
Clustering of genes through correlation have been done through hclust function in R 
statistical programming environment.  
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Fig 3.17 Heatmap of top differentially expressed genes between control and 5-
Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point. Genes plotted 
are ones which showed expression difference more than or equal to 450 between two 
samples. Clustering of genes through correlation have been done through hclust 
function in R statistical programming environment.  
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Fig 3.18. Heatmap of top differentially expressed genes between control and 6-
Methylindole treated samples at 72 hrs time point. Genes plotted are ones which 
showed expression difference more than or equal to 450 between two samples. 
Clustering of genes through correlation have been done through hclust function in R 
statistical programming environment.  
49 
 
 
            
Fig 3.19. Heatmap of top differentially expressed genes between control and 2, 5-
Dimethylindole treated samples at 72 hrs time point. Genes plotted are ones which 
showed expression difference more than or equal to 450 between two samples. 
Clustering of genes through correlation have been done through hclust function in R 
statistical programming environment.  
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Fig 3.20 Heatmap of top differentially expressed genes between control and 5-
Bromoindole-2-Carboxylic Acid treated samples at 72 hrs time point. Genes plotted 
are ones which showed expression difference more than or equal to 450 between two 
samples. Clustering of genes through correlation have been done through hclust 
function in R statistical programming environment.  
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Fig 3.21 Differential usage of alternative 5’ splice site that skips a pre-mature 
termination codon between control and 2, 5-Dimethylindole of hydrolase-like 
protein (AT5G17670). Comparison between differential inclusion of a pre-mature 
termination codon (highlighted in red square) between control sample (top four panels) 
2, 5-Dimethylindole treatment (lower four panels). This differential inclusion is 
achieved through differential usage of two splice sites. First GT splice site (left purple 
circle) has already been annotated in gene model (plotted at bottom of the shot). Second 
splice site GT (right purple circle) is a novel splice site that has been discovered in our 
data. This 5’ alternative splice event has been discovered through juncBASE and 
differential 5’ alternative donor was noted as statistically significant (p-value<0.01).  
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Fig 3.22 Differential exon skipping event in control vs. both 6-MethlyIndole and 2, 
5-Dimethylindole treated samples at 24 hrs of SR34A serine arginine rich protein 
splicing factor. Comparison between differential inclusion of exon 2 (highlighted in 
black square) between control sample (top four panels), 6-MethlyIndole (middle four 
panels) and 2, 5-Dimethylindole treatment (lower four panels). Less inclusion of exon 2 
under the effect of both 6-MethlyIndole and 2, 5-Dimethylindole than control sample is 
observed. This exon skipping event has been annotated in genome reference gene 
model and differential exon skipping was noted as statistically significant (p-
value<0.01).  
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Fig 3.23 Differential Intron retention event between control and 2,5-
Dimethylindole at 72 hrs time point of CPK28 calcium dependent protein kinase. 
Comparison between differential inclusion of intron (highlighted in black square) 
between control sample (top four panels) 2, 5-Dimethylindole treatment (lower four 
panels). This novel intron retention event has been discovered through juncBASE and 
differential intron retention was noted as statistically significant (p-value<0.01).   
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6-MethyIndole  
 
2,5 
Dimethylindole 
5-Bromoindole 2-carboxylic 
acid 
 
LHCB1.3 
PSAK 
S-ACP-DES6 
LHCA3 
AT1G62480 
ADH1 
PSBR 
AT1G07590,MT1A 
AT1G08115 
PSAO 
GAPC2 
DRT112 
LHCB1.2 
PSAF 
PSAG 
RBCS-1A 
GASA1 
ATEXT4 
AT2G01021 
GRP3S 
GRP3 
AT2G15960 
AT2G16586 
AT2G26500 
LHB1B1 
DOT1 
RPS31 
AT2G45180 
AHB1 
LHB1B2 
RCA 
CPuORF9,SAMDC1 
BAS1 
DJ1A 
AT3G15450 
AT3G41768,AT3G41979 
AT1G03220 
AT1G19020 
LHCB1.3 
PSAK 
AT1G32920 
AT1G56220 
LHCA3 
ACO2 
RPL10C 
ADH1 
PSBR 
AT1G07590,MT1A 
AT1G08115 
GAPC2 
PCR1,PCR2 
LHCB1.2 
PSAG 
RBCS-1A 
CPuORF28 
GASA1 
ATEXT4 
GSTU19 
AT2G01021 
GRP3S 
LHB1B1 
DOT1 
ERD15 
AT2G45180 
AHB1 
RBG7 
LHB1B2 
AT2G38240 
GAPC1 
DJ1A 
RAP2-3 
HR4 
AT1G03220 
AT1G05562 
SRC2 
GSTU24 
ARF2-A 
LHCB1.3 
LHCA3 
ACO2 
AT1G62480 
RPL10C 
ELF5A-3 
OPR1 
ADH1 
PSBR 
AT1G07590,MT1A 
AT1G08115 
PCR1,PCR2 
LHCB1.2 
PCR8 
ALDH7B4 
PSAG 
AT1G60730 
RBCS-1A 
CPuORF28 
ATKTI1 
GASA1 
ATEXT4 
GSTU19 
AT2G01021 
GRP3S 
GRP3 
AT2G16586 
CYP19-1 
LHB1B1 
DOT1 
ERD15 
Table3.1. Differentially Expressed genes between control and 
treatments at 24 hrs time point 
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LHCA2 
AT3G03270 
MT3 
PSAH1 
TCTP 
PSBT 
TIP1-2 
LHCA4 
LHCA1 
CURT1A 
PETC 
LHCB5 
STR15 
SAG21 
AZI1 
FSD1 
AT4G27450 
PSAE1 
XTH24 
PCKA 
FBA2 
AT5G01520,LHCB4.1 
ASP2 
RFS6 
GLN2 
LHCB3 
THI1 
PSBO1 
MT2B 
RBCS-3B 
RBCS-1B 
AT5G43580 
PER71 
AT5G65207 
 
BCA1 
AT3G03270 
MT3 
TCTP 
TIP1-2 
LHCA4 
LTP5 
LHCA1 
CURT1A 
AT4G08555 
LHCB5 
XTH23 
STR15 
AT4G39675 
SAG21 
FSD1 
AT4G27450 
XTH18 
PDC1 
ASP2 
LHCB3 
PSBO1 
RBCS-3B 
RBCS-2B 
AT5G65207 
 
AT2G45180 
AT2G47720,GSTF8 
AGT1 
AHB1 
RBG7 
GSTU7 
LHB1B2 
GAPC1 
DJ1A 
AT3G15450 
RAP2-3 
HR4 
DOX1 
AT3G03270 
HEL 
BGLU23 
MT2A 
TIP1-2 
LHCA4 
AAE3 
LHCA1 
CURT1A 
AT4G08555 
LHCB5 
AT4G33560 
STR15 
AT4G39675 
AT4G01860,AT4G01865,AT4G01870 
SAG21 
AZI1 
FSD1 
AT4G27450 
PDC1 
PCKA 
AT5G01520,LHCB4.1 
AT5G19440 
ASP2 
RAN1,RAN2,RPT6B 
AT5G26280,AT5G26300 
ATCP1 
AT5G51830 
LHCB3 
BGAL4 
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EXL2 
PSBO1 
AT5G66985 
FER1 
MT2B 
AT5G16960,P1 
RBCS-3B 
RBCS-2B 
UBC10 
AT5G54940 
AT5G61820 
PER71 
AT5G65207 
ORF111D,RRN5 
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6-MethyIndole  
 
2,5 
Dimethylindole 
5-Bromoindole 2-
carboxylic acid 
 
LHCB1.3 
PSBR 
AT1G07590,MT1A 
ELP 
SNOR105 
LHCB1.2 
AT1G54410 
RBCS-1A 
AT2G16586 
TIP1-1 
ERD15 
AT2G45180 
LHCB2.2 
LHCB2.1 
PSBX 
AT2G10940 
LHB1B2 
COR15B 
COR15A 
AT3G15450 
CCL 
BCA1 
BGLU23 
LHCA4 
AT4G30650 
AGP15 
KIN2 
SNOR108 
LHCB3 
THI1 
RBCS-3B 
RBCS-2B 
RBCS-1B 
XTH22 
 
PSBP1 
CAT3 
LHCB1.3 
PSAK 
FD2 
LHCA3 
PSBR 
AT1G07590,MT1A 
PSAO 
ELP 
LHCB6 
DRT112 
SNOR105 
PSAF 
PSAG 
RBCS-1A 
GLP1 
AT2G01021 
AT2G16586 
PSAE2 
LHB1B1 
ERD15 
AT2G45180 
PSBX 
AT2G10940 
RBG7 
PSBW 
AT2G33830 
LHB1B2 
LHCB4.2 
AT3G15450 
CCL 
LHCA2 
BCA1 
PSB27-1 
PSBP1 
MT1C 
APX1 
FD1 
GSTU24 
LFNR2 
RPL34 
LHCB1.3 
PSAK 
PRK 
GAPB 
PSAH2 
FD2 
LHCA3 
PSBR 
AT1G03140,PSAD2 
AT1G07590,MT1A 
PSAO 
ELP 
GAPA2 
LHCB6 
DHAR1 
DRT112 
EXT3 
AT1G21500 
SNOR105 
LHCB1.2 
PSAF 
AGP21 
PSAG 
RBCS-1A 
PSBY 
GLP1 
Table3.2. Differentially Expressed genes between control and 
treatments at 72 hrs time point 
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MT2A 
MT3 
PSAH1 
PSBT 
LHCA4 
LHCA1 
CURT1A 
LHCB5 
PSAL 
PSBQ1 
PSAD1 
PSBQ2 
FSD1 
PSAE1 
AT5G01520,LHCB4.1 
AT5G02160 
SNOR108 
LHCB3 
THI1 
PSBO1 
RBCS-3B 
PSAN 
ORF111D,RRN5 
 
GSTU19 
RPS17 
AT2G01021 
PDF2.3 
GRP3S 
AT2G16586 
PSAE2 
AT2G26500 
GSTF9 
RPL28 
LHB1B1 
TIP1-1 
RPS31 
ERD15 
AT2G45180 
CURT1B 
CP12-1 
LHCB2.1 
PSBX 
AT2G10940 
AGT1 
RBG7 
PSBW 
LHB1B2 
CP29B 
RCA 
COR15A 
GAPC1 
LHCB4.2 
BAS1 
AT3G15450 
TIP2-1 
GAPA1 
RPL12A 
LOX2 
TKL-1 
LHCA2 
CYP20-3 
CP12-2 
BCA1 
BGLU23 
MT2A 
PGK1,SDRB 
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PSAH1 
PSBT 
TIP1-2 
LHCA4 
PSBO2 
CP29A 
RPL17 
LHCA1 
AT3G63160 
CURT1A 
PETC 
ATPD 
LHCB5 
PSAL 
AT4G16980 
TUFA 
PSBQ1 
ACP4 
PSAD1 
PSBQ2 
GPX6 
PER42 
CP31A 
FSD1 
PSAE1 
AT4G32260 
SSR16 
SPE2 
SHM1 
FBA2 
AT5G01520,LHCB4.1 
AT5G02160 
AGP15 
BCA2 
KIN2 
NUDT24 
GLN2 
SNOR108 
LHCB3 
THI1 
PSBO1 
MT2B 
GER3 
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VSP1,VSP2 
RBCS-3B 
RBCS-2B 
RBCS-1B 
AT5G42530 
XTH22 
LTP4 
PSAN 
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CHAPTER 4: CONCLUSION AND FUTURE 
 PERSPECTIVES 
 
  In this study, 3 different Indole derivatives, 6-Methylindole, 2, 5-Dimethylindole, 
5-Bromoindole-2-Carboxylic Acid, have been used to target SR proteins in Arabidopsis 6 
days old seedlings. Paired end RNA-seq have been used to provide a full snapshot of the 
plant’s transcriptome after treatment at two time points 24 hrs and 72 hrs.   
  Interestingly, observation of global splicing pattern alteration under the influence 
of Indole derivatives used in this study indicate that in most treatments, 4 out of 6,  and 
specifically after certain onset of time, 72 hrs,  splicing inhibition promoted by those 
derivatives lead to significant enhancement of AS, mostly and specifically intron retention 
splicing events. This finding is strongly consistent with the hypothesis that ESE dependent 
splicing inhibition promoted by Indole derivative eventually result in splicing failure and 
more retained intron, especially in an organism where intron retention is extremely 
prevalent.  
  Identification of both genes differentially spliced and expressed revealed 
similarity in the affected systems and coupling of AS to gene expression. Most 
importantly, Photorespiration related genes were frequently and repeatedly altered, on AS 
or expression level, under different Indole derivatives treatments and time points. More 
interestingly RNA binding proteins and splicing factors were differentially spliced, a 
finding that is consistent with the prevalence of auto-regulatory nature of those genes.  
  Furthermore, insights into the molecular function of events showed differential 
splicing under treatment suggest various potential functional outcomes. In hydrolase-like 
protein (AT5G17670), novel alternative 5’ splice site skipped a pre-mature termination 
codon. In SR34a SR splicing factor, exon skipping event at the 5’ untranslated region may 
render the spliced transcript resistant to regulatory pathways target this region similar to 
what happens in metazoans. In CPK32 protein kinase, novel intron retention event, which 
function is unknown, may suggest an AS mediated alteration of kinase activity. This may 
further indicate strong coupling between post-transcriptional splicing and post-translation 
phosphorylation.  
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  Future directions of this research line shall include two main research lines. First, 
systematic structure activity relationship of Indole derivatives determination shall be 
conducted. More Indole derivatives, beyond those used in this study may be experimented 
on in-vitro splicing system and on different SR proteins shall give more insights into the 
specificity exhibited by different derivatives. Those studies are critically important for the 
development of Indole derivatives as splicing modulators in both therapeutic and research 
context.  
  Moreover, more splicing modulators that target different components of 
splicesomal machinery, rather than SR proteins, may be used to reveal more into the 
consequences of splicing modulation on Arabidopsis (or other plants)’s transcriptome. 
Alteration of AS through AOS against specific splicing event may be further used. This 
modulation of AS by targeting different splicing players shall continue to clarify more into 
the nature of landscape AS regulation mediated of gene expression, post-transcriptional 
and post-translational modifications.   
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